Pharmacotherapy in Acutely Anemic Jehovah’s Witnesses: An Evidence-Based Review

No abstract is available for this paper.

• Publication year

  2018

• Venue

  The Annals of Pharmacotherapy

• Publication date

  2018-03-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/1060028018766656PMID 29592539
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Low-dose erythropoietin treatment is not associated with clinical benefits in severely anaemic Jehovah's Witnesses: a plea for a change.

  2018cited by this paper
• Pegylated bovine carboxyhaemoglobin utilisation in a thrombotic thrombocytopenic purpura patient

  2017cited by this paper
• Treatment of individuals who cannot receive blood products for religious or other reasons

  2017cited by this paper
• Long‐lasting extreme anemia during the therapy of acute lymphoblastic leukemia in a Jehovah's Witness patient

  2016cited by this paper
• Hemoglobin-Based Oxygen Carrier for Traumatic Hemorrhagic Shock Treatment in a Jehovah’s Witness

  2016cited by this paper
• PEGylated Bovine Carboxyhemoglobin (SANGUINATE™): Results of Clinical Safety Testing and Use in Patients.

  2016cited by this paper
• Outcomes from cardiac surgery in Jehovah’s witness patients: experience over twenty-one years

  2016cited by this paper
• A Phase Ib open label, randomized, safety study of SANGUINATE™ in patients with sickle cell anemia

  2016cited by this paper
• Oral vitamin C supplementation reduces erythropoietin requirement in hemodialysis patients with functional iron deficiency

  2016cited by this paper
• Management of the Jehovah's Witness in Obstetrics and Gynecology: A Comprehensive Medical, Ethical, and Legal Approach

  2016cited by this paper
• Outcome of Jehovah's Witnesses after adult cardiac surgery: systematic review and meta‐analysis of comparative studies

  2016cited by this paper
• CASE 12-2016 Ascending Aorta Dissection in a Jehovah's Witness Patient on Warfarin.

  2016cited by this paper
• A Simple “Blood-Saving Bundle” Reduces Diagnostic Blood Loss and the Transfusion Rate in Mechanically Ventilated Patients

  2015cited by this paper
• Iron-deficiency anemia.

  2015cited by this paper
• Successful Rescue Therapy for Severe Acute Anemia: Managing the Critically Ill Jehovah's Witness

  2015cited by this paper
• Heterogeneity in Blood Product Acceptance Among Antenatal Patients of the Jehovah's Witness Faith

  2015cited by this paper
• Prophylactic hypothermia and neuromuscular blockade to limit myocardial oxygen demand in a critically anemic Jehovah's Witness after emergency surgery†

  2014cited by this paper
• Risk‐adjusted clinical outcomes in patients enrolled in a bloodless program

  2014cited by this paper
• Epoetin in the ‘untransfusable’ anaemic patient: a retrospective case series and systematic analysis of literature case reports

  2014cited by this paper
• Hemoglobin-based oxygen carriers: disclosed history and the way ahead: the relativity of safety.

  2014cited by this paper
• An update on mortality and morbidity in patients with very low postoperative hemoglobin levels who decline blood transfusion (CME)

  2014cited by this paper
• Ethical issues in the care of Jehovah's Witnesses

  2014cited by this paper
• Postoperative management of severe acute anemia in a Jehovah's Witness

  2014cited by this paper
• PEGylated carboxyhemoglobin bovine (SANGUINATE): results of a phase I clinical trial.

  2014cited by this paper
• How do we treat life‐threatening anemia in a Jehovah's Witness patient?

  2014cited by this paper
• Savoring every drop – Vampire or Mosquito?

  2014cited by this paper
• Jehovah's Witnesses and cardiac surgery: a single institution's experience

  2014cited by this paper
• Jehovah’s Witness patients presenting with ruptured ectopic pregnancies: two case reports

  2014cited by this paper
• Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial.

  2013cited by this paper
• High-risk anaemic Jehovah's Witness patients should be managed in the intensive care unit.

  2013cited by this paper
• Supportive treatment of severe anaemia in a Jehovah's Witness with severe trauma.

  2013cited by this paper
• Impact of Erythropoietin on Intensive Care Unit Patients

  2013cited by this paper
• Eight‐year experience of bloodless surgery at a tertiary care hospital in Korea

  2013cited by this paper
• Spanish Consensus Statement on alternatives to allogeneic blood transfusion: the 2013 update of the "Seville Document".

  2013cited by this paper
• Use of recombinant activated factor VII in Jehovah's Witness patients with critical bleeding

  2013cited by this paper
• Treatment monitoring and mortality risk adjustment in anaemic Jehovah's Witnesses

  2013cited by this paper
• Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: a systematic review.

  2013cited by this paper
• Stress ulcer prophylaxis versus placebo or no prophylaxis in critically ill patients

  2013cited by this paper
• Alternatives to blood transfusion

  2013cited by this paper
• Balancing potential risks and benefits of hemoglobin‐based oxygen carriers

  2013cited by this paper
• Mortality risk stratification in severely anaemic Jehovah's Witness patients

  2012cited by this paper
• A randomized, double-blind, placebo-controlled study to assess the effect of recombinant human erythropoietin on functional outcomes in anemic, critically ill, trauma subjects: the Long Term Trauma Outcomes Study.

  2012cited by this paper
• Bleeding in a Jehovah’s Witness patient undergoing a redo aortic valve replacement controlled with cryoprecipitate and a prothrombin complex concentrate

  2012cited by this paper
• Jehovah's Witnesses and autonomy: honouring the refusal of blood transfusions

  2012cited by this paper
• Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

  2012cited by this paper
• 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines.

  2011cited by this paper
• Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma).

  2011cited by this paper
• When Blood Is Not an Option: Factors Affecting Survival After the Use of a Hemoglobin-Based Oxygen Carrier in 54 Patients with Life-Threatening Anemia

  2010cited by this paper
• Optimization of tissue oxygenation in critically ill Jehovah's Witness patients.

  2010cited by this paper
• Pharmacokinetics and pharmacodynamics of six epoetin alfa dosing regimens in anemic critically ill patients without acute blood loss*

  2009cited by this paper
• The Use of Barbiturate Coma as Salvage Therapy in a Postoperative Jehovah's Witness Patient with Life-Threatening Anemia

  2009cited by this paper
• HBOC‐201 use in traumatic brain injury: case report and review of literature

  2009cited by this paper
• Management of adult Jehovah's Witness patients with acute bleeding.

  2009cited by this paper
• Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis.

  2008cited by this paper
• Anemia of Critical Illness

  2008cited by this paper
• Reduction of blood loss from laboratory testing in hospitalized adult patients using small-volume (pediatric) tubes.

  2008cited by this paper
• The contemporary approach to the care of Jehovah's witnesses.

  2008cited by this paper
• Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia.

  2008cited by this paper
• Recombinant Human Erythropoietin Therapy in Critically Ill Jehovah's Witnesses

  2008cited by this paper
• Erythropoietin-receptor agonists in critically ill patients: a meta-analysis of randomized controlled trials

  2007cited by this paper
• Cirugía cardiaca sin sangre en testigos de Jehová: resultados frente a grupo control

  2007cited by this paper
• Clinical aspects of iron use in the anemia of kidney disease.

  2007cited by this paper
• Efficacy and safety of epoetin alfa in critically ill patients.

  2007cited by this paper
• [Bloodless cardiac surgery in Jehovah's witnesses: outcomes compared with a control group].

  2007cited by this paper
• Recombinant Human Erythropoietin in Severe Anaemia: Issues of Dosing and Duration

  2006cited by this paper
• Anemia, transfusion, and phlebotomy practices in critically ill patients with prolonged ICU length of stay: a cohort study

  2006cited by this paper
• UNRESOLVED ISSUES IN DIALYSIS: Managing Erythropoietin Hyporesponsiveness

  2006cited by this paper
• Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: A randomized, double-blind, placebo-controlled trial*

  2006cited by this paper
• A Jehovah's Witness with Complex Abdominal Trauma and Coagulopathy: Use of Factor VII and a Review of the Literature

  2005cited by this paper
• Jehovah's Witness children: when religion and the law collide.

  2005cited by this paper
• Children of Jehovah’s Witnesses and adolescent Jehovah’s Witnesses: what are their rights?

  2005cited by this paper
• Do blood tests cause anemia in hospitalized patients?

  2005cited by this paper
• Severe gastrointestinal haemorrhage responding to recombinant factor VIIa in a Jehovah's Witness with refractory immune thrombocytopenia.

  2004cited by this paper
• The CRIT Study: Anemia and blood transfusion in the critically ill—Current clinical practice in the United States*

  2004cited by this paper
• Use of Epoetin Alfa in Critically III Patients

  2004cited by this paper
• Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (NovoSeven).

  2003cited by this paper
• Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial.

  2002cited by this paper
• Anemia and blood transfusion in critically ill patients.

  2002cited by this paper
• Terminally ill patients and Jehovah's Witnesses: teaching acceptance of patients' refusals of vital treatments

  2002cited by this paper
• Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion

  2002cited by this paper
• Blunted erythropoietic response to anemia in multiply traumatized patients

  2001cited by this paper
• Use of desmopressin and erythropoietin in an anaemic Jehovah’s Witness patient with severely impaired coagulation capacity undergoing stentless aortic valve replacement

  2001cited by this paper
• Why some Jehovah's Witnesses accept blood and conscientiously reject official Watchtower Society blood policy

  2000cited by this paper
• Erythropoietin with Iron Supplementation To Prevent Allogeneic Blood Transfusion in Total Hip Joint Arthroplasty

  2000cited by this paper
• Anaesthetic management of Caesarean section in an elderly parturient with pre‐eclampsia

  1999cited by this paper
• A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group.

  1999cited by this paper
• Bioethics of the refusal of blood by Jehovah's Witnesses: Part 3. A proposal for a don't-ask-don't-tell policy.

  1999cited by this paper
• Hyperbaric oxygen therapy in the management of severe acute anaemia in a Jehovah's Witness

  1999cited by this paper
• Human cardiovascular and metabolic response to acute, severe isovolemic anemia.

  1998cited by this paper
• A randomized controlled study of iron supplementation in patients treated with erythropoietin.

  1996cited by this paper
• Combined aprotinin and erythropoietin use for blood conservation: results with Jehovah's Witnesses.

  1994cited by this paper
• Jehovah's Witnesses and Blood Transfusion: Physicians' Attitudes and Legal Precedents

  1984cited by this paper

• Veno-Venous ECMO Support in the Management of a Jehovah’s Witness with Severe COVID-19: A Case Report and Literature Review

  2025cites this paper
• Darbepoetin alfa use in trauma and acute care surgery patients who abstain from blood products: A case series and discussion.

  2025cites this paper
• Management of Severe Anemia in a Jehovah’s Witness Patient With Lung Abscess Secondary to Malpositioned Laparoscopic Adjustable Gastric Band: A Case Report

  2024cites this paper
• Management strategies for perioperative anaemia in the severely burn-injured Jehovah's Witness patients who decline a blood transfusion: A systematic review with illustrative case reports.

  2022cites this paper
• Blood transfusion and alternatives in Jehovah's Witness patients

  2021cites this paper
• Extracorporeal membrane oxygenation in Jehovah's Witness patients: Case report, literature review, and summary of recommendations.

  2021cites this paper
• Transfusion replacement strategies in Jehovah's Witnesses and others who decline blood products.

  2020cites this paper
• Preoperative considerations for Jehovah's Witness patients: a clinical guide.

  2020cites this paper
• Artificial Oxygen Carriers—Past, Present, and Future—a Review of the Most Innovative and Clinically Relevant Concepts

  2019cites this paper
• Early Experiences With PEGylated Carboxyhemoglobin Bovine in Anemic Jehovah’s Witnesses: A Case Series and Review of the Literature

  2018cites this paper
• A Bridge to Bloodless Surgery: Use of Hemoglobin-Based Oxygen Carrier for Anemia Treatment and Autologous Blood Preservation During Redo Pulmonic Valve Replacement.

  2018cites this paper